Recent

% | $
Quotes you view appear here for quick access.

Gilead Sciences Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • pkornie@sbcglobal.net pkornie Jan 20, 2012 7:43 AM Flag

    Dead cat bounce...suckers. Now I'm pissed

    << Message board name is either empty or non-existent >>.(___O___).

    << 1:31AM Gilead Sciences: FDA approves new formulations of Viread for use by children living with HIV (GILD) 46.26 : Co announces the FDA has approved Viread in combination with other antiretroviral agents for the treatment of HIV-1 infection in pediatric patients ages 2-12. The FDA approved a supplemental New Drug Application for three lower-strength once-daily tablets of Viread in doses of 150 mg, 200 mg and 250 mg for children ages 6-12. The agency also approved a New Drug Application for an oral powder formulation of Viread for children ages 2-5. The pediatric regulatory applications for Viread were supported by clinical data from a Phase 3 safety and efficacy study of a Viread-containing antiretroviral regimen compared to an antiretroviral regimen containing zidovudine or stavudine in HIV-infected treatment-experienced children ages 2-12. The safety profile observed in the study was consistent with that observed in clinical trials in adults. The applications were submitted to the FDA on July 18, 2011.

    >>

    o.

    .

    Sentiment : Strong Buy

 
GILD
81.37-0.15(-0.18%)Sep 23 4:00 PMEDT